JENNIFER GIDDENS: Open Payments
NPI 1396294229 · BOAZ, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 34 payments from 15 companies in 2025. Trend: 2023 $1,990 · 2024 $1,469 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Exact Sciences Corporation | 4 | $58 |
| Indivior Inc. | 2 | $56 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Gilead Sciences, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
Products named: Kerendia, VERQUVO, SUBLOCADE, Cologuard Collection Kit, RECORLEV, FANAPT, XIFAXAN, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
